GV joins in another $76 million for neurobehavioral health company Blackthorn’s plan to treat mental disorders

19:08 13.06.2019
There are numerous challenges to finding effective treatments for mental disorders. However, Blackthorn Therapeutics, a neurobehavioral health company using machine learning to create personalized medicine for mental health, is betting its technological approach to finding drugs that work will put it ahead of the competition. Lucky for them, GV and other biotech investors have shown […]...
  358